8-K: Current report
8-K: Current report
NRX Pharmaceuticals | 8-K: Current report
NRX Pharmaceuticals | 8-K: NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
NRX Pharmaceuticals | 8-K: Current report
NRX Pharmaceuticals | 8-K: Current report
NRX Pharmaceuticals | DEFA14A: Others
NRX Pharmaceuticals | DEFA14A: Others
NRX Pharmaceuticals | DEFA14A: Others
NRX Pharmaceuticals | DEF 14A: Definitive information statements
NRX Pharmaceuticals | 8-K: Current report
NRX Pharmaceuticals | 8-K: Current report
NRX Pharmaceuticals | 8-K: Current report
NRX Pharmaceuticals | 8-K: Current report
NRX Pharmaceuticals | 8-K: Current report
NRX Pharmaceuticals | 8-K: Current report
NRX Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition
NRX Pharmaceuticals | 8-K: Current report
NRX Pharmaceuticals | 8-K: Current report
NRX Pharmaceuticals | DEF 14A: Definitive information statements
No Data